Immunowakeup microsystem as well as preparation method and application thereof
A microsystem and microsome technology, which can be used in pharmaceutical formulations, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc., can solve the problems of restricting the widespread use of BMT, high requirements for treatment facilities, and expensive treatment costs. , to achieve the effect of improving immune killing function, overcoming immune tolerance, avoiding risks and serious side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] A preparation method of immune awakening microsystem
[0035] 1. Preparation of immune microsomes
[0036] 1. Preparation of encapsulated microsomes:
[0037] Polyethylene glycol lactic acid (PLG poly(D, L-lactide-co-glycolide)), RG503BoehringerIngelheim Mr2400050:50 (w / w), 6% w / v, added bovine serum albumin (RIA grade Sigma) containing 1% , and rIL-2 (Roche) pre-dissolved in the buffer solution were added to dichloromethane, stirred at a medium speed to form an emulsion (w / o), quickly added emulsifier polyvinyl alcohol 10% PVAw / v, stirred at high speed in an ice bath for 30 Minutes into an emulsion (w / o / w), stirred overnight at room temperature at low speed, and evaporated the organic solvent. After solidification, the microspheres were collected by centrifugation, washed three times with double distilled water, and dried in vacuum. The yield was greater than 70%. The microspheres are dispersed in distilled water by ultrasonic waves, one drop is placed on a glass slid...
Embodiment 2
[0055] Experiments on animal models of solid tumors and leukemia treated with IMS
[0056] 1. In the mouse OVA tumor experiment, 6-10 week old mouse C57BL / 6 was used as host recipient, and Balb / c was used as donor CD4+ cells to prepare IMS. OVA-expressing EG-7 cells10 6 Inject C57BL / 6 mice intradermally, and start treatment after the tumor reaches 5-7mm five days later. In the B-cell leukemia experiment, 6-10 week-old mouse Balb / c was used as host recipient, and C57BL / 6 was used as donor CD4+ cells to prepare IMS. When BCL2 cells 10E6 were injected into Balb / c mice, the spleen expanded to twice its original size one week later, and peripheral blood lymphocytes were destroyed and lysed before treatment. Donor CD4+ cells were isolated from splenocytes, activated and cross-linked immune microsomes, and IMS was prepared according to the steps in Example 1.
[0057] 2. Survival rate: After one week, 10E5 IMS was injected intravenously, and after two weeks, 10E5 IMS was injected ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 